Biolight Life Sciences Ltd
TASE:BOLT
Biolight Life Sciences Ltd
Operating Income
Biolight Life Sciences Ltd
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
B
|
Biolight Life Sciences Ltd
TASE:BOLT
|
Operating Income
-₪10.7m
|
CAGR 3-Years
2%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
9%
|
Compugen Ltd
NASDAQ:CGEN
|
Operating Income
-$13m
|
CAGR 3-Years
26%
|
CAGR 5-Years
11%
|
CAGR 10-Years
0%
|
|
Q
|
Quoin Pharmaceuticals Ltd
NASDAQ:QNRX
|
Operating Income
-$9.1m
|
CAGR 3-Years
-35%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
N/A
|
See Also
What is Biolight Life Sciences Ltd's Operating Income?
Operating Income
-10.7m
ILS
Based on the financial report for Dec 31, 2023, Biolight Life Sciences Ltd's Operating Income amounts to -10.7m ILS.
What is Biolight Life Sciences Ltd's Operating Income growth rate?
Operating Income CAGR 10Y
9%
Over the last year, the Operating Income growth was -3%. The average annual Operating Income growth rates for Biolight Life Sciences Ltd have been 2% over the past three years , and 9% over the past ten years .